Metraipolis › archive › dc_385334fbc801
Tertiary lymphoid structures as biomarkers and therapeutic targets in neoadjuvant cancer immunotherapy — Europe PMC PMID:42459699
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42459699
- DOI
- 10.3389/fimmu.2026.1882195
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T13:53:59.073Z
- SHA-256 of the archived text
c02af3b5d2d4253f7d4f36df30818b0b73997a47fbc64aa89c3dbe136ff5ac77- Stable URL of this page
https://metraipolis.com/documento/dc_385334fbc801
How to cite
Tertiary lymphoid structures as biomarkers and therapeutic targets in neoadjuvant cancer immunotherapy — Europe PMC PMID:42459699 — Europe PMC (en), https://europepmc.org/article/MED/42459699 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_385334fbc801 (Metraipolis archive dc_385334fbc801, sha256 c02af3b5d2d4253f7d4f36df30818b0b73997a47fbc64aa89c3dbe136ff5ac77)
BibTeX
@misc{dc385334fbc801,
title = {Tertiary lymphoid structures as biomarkers and therapeutic targets in neoadjuvant cancer immunotherapy — Europe PMC PMID:42459699},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42459699},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_385334fbc801; sha256 c02af3b5d2d4253f7d4f36df30818b0b73997a47fbc64aa89c3dbe136ff5ac77},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42459699. Agents can read the archived copy with the MCP tool read_document.